SXC-2023 is a cystine–glutamate antiporter (SLC7A11; System xc- or Sxc) activator or glutamate modulator which is under development for the treatment of impulse control disorders such as trichotillomania (hair-pulling disorder).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.